Andrew T Kuykendall

33PUBLICATIONS
180CO-AUTHORS
Medical mycologyPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsRespiratory diseasesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

|Mar 05, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Jan 26, 2026
Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Luis E Aguirre, Haesook T Kim, Hany Elmariah

|Aug 21, 2025
Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib.

Francesca Palandri, Filippo Branzanti, Massimiliano Bonifacio

|Dec 17, 2024
Anemia in Myelofibrosis: A Focus on Proactive Management and the Role of Momelotinib.

Haifa Kathrin Al-Ali, Andrew T Kuykendall, Catherine E Ellis

Pageof 6

Frequent Collaborators

17 joint publications

Rami S Komrokji

8 joint publications

David Sallman

8 joint publications

Onyee Chan

5 joint publications

Francesca Palandri